Cell surface IL-1α trafficking is specifically inhibited by interferon-γ, and associates with the membrane via IL-1R2 and GPI anchors.
Accepted version
Peer-reviewed
Repository URI
Repository DOI
Change log
Authors
Abstract
IL-1 is a powerful cytokine that drives inflammation and modulates adaptive immunity. Both IL-1α and IL-1β are translated as proforms that require cleavage for full cytokine activity and release, while IL-1α is reported to occur as an alternative plasma membrane-associated form on many cell types. However, the existence of cell surface IL-1α (csIL-1α) is contested, how IL-1α tethers to the membrane is unknown, and signaling pathways controlling trafficking are not specified. Using a robust and fully validated system, we show that macrophages present bona fide csIL-1α after ligation of TLRs. Pro-IL-1α tethers to the plasma membrane in part through IL-1R2 or via association with a glycosylphosphatidylinositol-anchored protein, and can be cleaved, activated, and released by proteases. csIL-1α requires de novo protein synthesis and its trafficking to the plasma membrane is exquisitely sensitive to inhibition by IFN-γ, independent of expression level. We also reveal how prior csIL-1α detection could occur through inadvertent cell permeabilisation, and that senescent cells do not drive the senescent-associated secretory phenotype via csIL-1α, but rather via soluble IL-1α. We believe these data are important for determining the local or systemic context in which IL-1α can contribute to disease and/or physiological processes.
Description
Keywords
Journal Title
Conference Name
Journal ISSN
1521-4141
Volume Title
Publisher
Publisher DOI
Rights
Sponsorship
British Heart Foundation (None)
British Heart Foundation (RG/16/8/32388)
British Heart Foundation (FS/18/19/33371)
British Heart Foundation (None)
British Heart Foundation (FS/18/19/33371)
British Heart Foundation (None)
British Heart Foundation (None)
British Heart Foundation (CH/2000003/12800)
British Heart Foundation (PG/16/11/32021)
British Heart Foundation (RG/20/2/34763)
British Heart Foundation (PG/16/24/32090)
British Heart Foundation (FS/20/19/34976)